These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33191223)

  • 21. Discovery and quantitative structure-activity relationship study of lepidopteran HMG-CoA reductase inhibitors as selective insecticides.
    Zang YY; Li YM; Yin Y; Chen SS; Kai ZP
    Pest Manag Sci; 2017 Sep; 73(9):1944-1952. PubMed ID: 28247468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential natural inhibitors of xanthine oxidase and HMG-CoA reductase in cholesterol regulation: in silico analysis.
    Marahatha R; Basnet S; Bhattarai BR; Budhathoki P; Aryal B; Adhikari B; Lamichhane G; Poudel DK; Parajuli N
    BMC Complement Med Ther; 2021 Jan; 21(1):1. PubMed ID: 33386071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of recombinant enzyme 3-hydroxy-3-methylglutaryl-CoA reductase from Candida glabrata by α-asarone-based synthetic compounds as antifungal agents.
    Andrade-Pavón D; Ortiz-Álvarez J; Sánchez-Sandoval E; Tamariz J; Hernández-Rodríguez C; Ibarra JA; Villa-Tanaca L
    J Biotechnol; 2019 Feb; 292():64-67. PubMed ID: 30690093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells.
    Petras SF; Lindsey S; Harwood HJ
    J Lipid Res; 1999 Jan; 40(1):24-38. PubMed ID: 9869647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihyperlipidemic studies of newly synthesized phenolic derivatives: in silico and in vivo approaches.
    Aqeel MT; Ur-Rahman N; Khan AU; Ashraf Z; Latif M; Rafique H; Rasheed U
    Drug Des Devel Ther; 2018; 12():2443-2453. PubMed ID: 30127594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploration of natural product ingredients as inhibitors of human HMG-CoA reductase through structure-based virtual screening.
    Lin SH; Huang KJ; Weng CF; Shiuan D
    Drug Des Devel Ther; 2015; 9():3313-24. PubMed ID: 26170618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Istvan ES
    Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QSAR & complex network study of the HMGR inhibitors structural diversity.
    García I; Diop YF; Gómez G
    Curr Drug Metab; 2010 May; 11(4):307-14. PubMed ID: 20446903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Explaining statin inhibition effectiveness of HMG-CoA reductase by quantum biochemistry computations.
    da Costa RF; Freire VN; Bezerra EM; Cavada BS; Caetano EW; de Lima Filho JL; Albuquerque EL
    Phys Chem Chem Phys; 2012 Jan; 14(4):1389-98. PubMed ID: 22159045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of HMG-CoA reductase inhibitory and antioxidant effects of various hydroxycoumarin derivatives.
    Ozalp L; Danış Ö; Yuce-Dursun B; Demir S; Gündüz C; Ogan A
    Arch Pharm (Weinheim); 2020 Oct; 353(10):e1900378. PubMed ID: 32648617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An in vitro and molecular informatics study to evaluate the antioxidative and β-hydroxy-β-methylglutaryl-CoA reductase inhibitory property of Ficus virens Ait.
    Iqbal D; Khan MS; Khan MS; Ahmad S; Srivastava AK
    Phytother Res; 2014 Jun; 28(6):899-908. PubMed ID: 24151056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognized sequence and conformation in design of linear peptides as a competitive inhibitor for HMG-CoA reductase.
    Pak VV; Koo M; Yun L; Kwon DY
    J Mol Recognit; 2007; 20(3):197-203. PubMed ID: 17486664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycyrrhizic acid attenuates growth of Leishmania donovani by depleting ergosterol levels.
    Dinesh N; Neelagiri S; Kumar V; Singh S
    Exp Parasitol; 2017 May; 176():21-29. PubMed ID: 28242356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioactivities of
    Guedes L; Reis PBPS; Machuqueiro M; Ressaissi A; Pacheco R; Serralheiro ML
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31652501
    [No Abstract]   [Full Text] [Related]  

  • 35. Peptide design of a competitive inhibitor for HMG-CoA reductase based on statin structure.
    Pak VV; Kim SH; Koo M; Lee N; Shakhidoyatov KM; Kwon DY
    Biopolymers; 2006; 84(6):586-94. PubMed ID: 16886212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning, Purification, and Characterization of the Catalytic C-Terminal Domain of the Human 3-Hydroxy-3-methyl glutaryl-CoA Reductase: An Effective, Fast, and Easy Method for Testing Hypocholesterolemic Compounds.
    Curcio R; Aiello D; Vozza A; Muto L; Martello E; Cappello AR; Capobianco L; Fiermonte G; Siciliano C; Napoli A; Dolce V
    Mol Biotechnol; 2020 Feb; 62(2):119-131. PubMed ID: 31758489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant Schistosoma mansoni 3-hydroxymethylglutaryl-coenzyme-A reductase has different inhibitor kinetics compared to the mammalian host enzyme.
    El-Meanawy A; Hammd H; Chen GZ; Rottman F; Bennett JL
    Trop Gastroenterol; 2005; 26(3):132-5. PubMed ID: 16512462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanism for inhibition of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase by rosuvastatin.
    Holdgate GA; Ward WH; McTaggart F
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):528-31. PubMed ID: 12773150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketanserin, an antidepressant, exerts its antileishmanial action via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) enzyme of Leishmania donovani.
    Singh S; Dinesh N; Kaur PK; Shamiulla B
    Parasitol Res; 2014 Jun; 113(6):2161-8. PubMed ID: 24728519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and docking of highly hypolipidemic agents: Schizosaccharomyces pombe as a new model for evaluating alpha-asarone-based HMG-CoA reductase inhibitors.
    Argüelles N; Sánchez-Sandoval E; Mendieta A; Villa-Tanaca L; Garduño-Siciliano L; Jiménez F; Cruz Mdel C; Medina-Franco JL; Chamorro-Cevallos G; Tamariz J
    Bioorg Med Chem; 2010 Jun; 18(12):4238-48. PubMed ID: 20576575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.